Article
Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer.
Cancer medicine - 1 Feb 2021
Loukovaara Mikko, Pasanen Annukka, Bützow Ralf
Abstract excerpt
BACKGROUND: Mismatch repair (MMR) system has been implicated in the response of mammalian cells to ionizing radiation and DNA damaging agents. We investigated the value of the MMR system in predicting response to adjuvant therapy in endometrial cancer. METHODS: This was a single institution retrospective study. MMR protein status of endometrial carcinomas was assessed by immunohistochemistry. MMR deficient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
